%20and%20Batch%20Production%20Records%20(BPR).png)
Dr Ravleen Singh Khurana, MD, Nitika Pharmaceutical Specialities
Speaker in this video:
Dr Ravleen Singh Khurana, MD, Nitika Pharmaceutical Specialities
Topic: Role of low nitrite excipients in nitrosamines risk mitigation
Key Highlights:
[1] Excipients may contribute to the formation of Nitrosamines through precursor substances present in the excipient (e.g. nitrites, amines). Nitrite impurities are found in most of the commonly used excipients, at least in traces.
[2] Risk control for nitrosamine impurities in drug products is currently a major challenge in the industry.
[3] Incorporate nitrosamine risk mitigation during excipient development. Control reactive species (e.g., nitrites, amines) through robust design.
The post Dr Ravleen Singh Khurana, MD, Nitika Pharmaceutical Specialities appeared first on Express Pharma.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0
